UAE

Country-by-country labeling requirements for medical devices across MENA — Saudi Arabia (Arabic+English mandatory), UAE (Arabic with equal prominence), Egypt (Arabic or English), Israel (Hebrew+Arabic+English for consumer), Turkey (Turkish for consumer). Halal certification frameworks (GSO 2055-1:2015, SFDA-approved logos, UAE MOIAT, Qatar MOPH). UDI requirements across Saudi Arabia, UAE, Egypt, and Turkey.

Complete guide to digital health and AI medical device regulation across MENA — SFDA MDS-G27 guidance on digital health products (SaMD, mHealth, DTx, AI/ML, telemedicine, wearables, VR/AR), UAE EDE AI registration frameworks and National AI Strategy 2031, Turkey TITCK software medical device classification and exclusion list, Israel AMAR software requirements, and practical compliance strategies for each market.

Complete guide to in vitro diagnostic (IVD) registration across MENA — Saudi SFDA IVD classification (A–D) and companion diagnostic guidance, UAE EDE IVD requirements and fees, Egypt EDA IVD classes with ISO 15189/CLSI performance evaluation, Turkey TITCK IVDR-aligned framework, Israel AMAR IVD declaration route, and point-of-care testing requirements.

Complete guide to medical device clinical trial requirements across MENA — Saudi SFDA MDS-REQ-2 clinical trial framework (295 studies evaluated, 157 approved), UAE clinical investigation pathways, Egypt EDA Clinical Trials Law 214/2020 with three authorization pathways, Turkey TITCK Regulation on Clinical Trials, Israel MOH oversight, Qatar Law 6/2025, and practical strategies for multi-country trial management.

Practical guide to medical device import, customs duties, and free zone strategies across MENA — GCC Common Customs Tariff (5% standard rate), Saudi SABER/ZATCA procedures and 2026 tariff code updates, UAE EDE import requirements and free zone advantages (DHCC, DSP), Egypt EDA import approval and customs clearance, Turkey TITCK import controls, and optimization strategies for duty reduction.

Comprehensive analysis of the Middle East & North Africa medical device market — $24.6B in 2025 growing to $35B by 2032 at 5.1% CAGR. Saudi Arabia's $35.5B Global Health Exhibition deals, 400 GCC healthcare transactions (2021–2025), UAE $3.18B market, Egypt $4.37B, digital health at 19.6% CAGR, and smart devices growing at 10.16% CAGR.

How medical devices get reimbursed across MENA — Saudi Arabia CHI/NPHIES/AR-DRG value-based system, UAE mandatory insurance (Daman/Thiqa/AED 320 basic plan), Turkey SGK SUT codes and DMO procurement, Israel Health Basket, and Egypt UHIA universal insurance rollout. Market data, fees, co-payments, and market access strategies for device manufacturers.

Complete guide to post-market surveillance and vigilance requirements for medical devices across MENA — SFDA MDS-REQ11 (2-day/10-day/30-day reporting, change notifications, 90-day renewal), UAE EDE biennial PSUR for high-risk devices, Turkey TITCK 6-month shortage notification, Israel IRH periodic post-marketing reports, and Egypt EDA vigilance obligations.

How Saudi Arabia's HSTP (290 hospitals privatized, private sector 40% to 65%, SAR 260B health budget, LCGPA 40% local content, NIDLP 40% pharma localization) and UAE's Operation 300bn (AED 300B industrial GDP target, DHCC 100% foreign ownership, EDE regulatory framework) are reshaping medical device market entry across the Gulf.

How to register medical devices in the UAE under the Emirates Drug Establishment (EDE) — classification, fees, LAR requirements, DHA vs DOH differences, and the full step-by-step process after the 2026 MOHAP transition.

A strategic map of 25+ countries where CE marking provides regulatory leverage — organized by mechanism: full reliance, abridged review, evidence-only acceptance, and reference-only. Know which markets your CE Mark unlocks and what extra steps remain.

How to register medical devices in Saudi Arabia, UAE, and the GCC — SFDA requirements, UAE regulatory framework, GCC harmonization, and practical market entry guidance.